Tenderwize
Back to tender search

Open house discount agreements for the active ingredient Baricitinib, ATC L04AF02

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 196 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Baricitinib, ATC L04AF02

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

The buyer reserves the right to replace open-house contracts with exclusive discount agreements at any time, automatica...

No commitment on minimum quantities or volumes; actual uptake depends on prescribing behavior and patient needs.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Supply of pharmaceutical products containing Baricitinib
  • Non-exclusive discount agreements under §130a Abs. 8/130c Abs. 1 SGB V
Show full summary

This is an open-house model for non-exclusive discount agreements (Rabattverträge) on the active ingredient Baricitinib (ATC L04AF02) by AOK Rheinland-Pfalz/Saarland. The procedure is not a formal EU procurement but a voluntary transparency publication. All interested pharmaceutical companies can join at any time during the 24-month maximum contract duration, with first possible start on 01.05.2025. No estimated value is provided. The contract may be replaced by exclusive agreements during its term.

Risks

The buyer reserves the right to replace open-house contracts with exclusive discount agreements at any time, automatica...

No commitment on minimum quantities or volumes; actual uptake depends on prescribing behavior and patient needs.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Pharmaceutical companies only
  • Products must be authorized and marketable in Germany
  • Proof of marketability via Lauer-Taxe listing or AMIce database

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria specified; all participants are accepted under uniform conditions.

Buyer

Lots (1)

LOT-0001

Open house discount agreements for the active ingredient Baricitinib, ATC L04AF02

Non-exclusive discount agreements for Baricitinib. All pharmaceutical companies can participate under uniform conditions. Contracts run for up to 24 months, starting 01.05.2025. The buyer may replace these with exclusive contracts at any time. First deadline for initial agreements: 31.03.2025; thereafter, monthly deadlines apply.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

Apr 2025 - Apr 2027

Category

Pharmaceutical products

Award Criteria

No award criteria specified; all participants are accepted under uniform conditions.

Deadline

Expired Mar 31, 2025

Procurement Details

Publication date
12 Mar 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
164264-2025

Documents (1)

Similar tenders